Hochschulschrift
Functional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
- Weitere Titel
-
Funktionelle Evaluierung von HMGB1 als immuntherapeutisches Effektormolekül für zellbasierte Vakzinierungsstrategien
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Bremen, Universität Bremen, Diss., 2013
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Bremen
- (wer)
-
Staats- und Universitätsbibliothek Bremen
- (wann)
-
2013
- Urheber
-
Willenbrock, Saskia
- Beteiligte Personen und Organisationen
-
Murua Escobar, Hugo
Bullerdiek, Jörn
Dotzauer, Andreas
- URN
-
urn:nbn:de:gbv:46-00103158-19
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
12.03.20252025, 02:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Willenbrock, Saskia
- Murua Escobar, Hugo
- Bullerdiek, Jörn
- Dotzauer, Andreas
- Staats- und Universitätsbibliothek Bremen
Entstanden
- 2013
Ähnliche Objekte (12)
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Current status of dendritic cell-based tumor vaccination
Advances in Cell-based Therapeutic Process Development
Editorial: Effector functions of therapeutic antibodies
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic vaccination strategies : with 9 tables
The Use of Cell-based Approaches for Inducing Therapeutic Vascularization
Novel cell-penetrating effector proteins for therapeutic applications derived from Yersinia enterocolitica
B cell immunity in lung transplant rejection - effector mechanisms and therapeutic implications
Isolation and characterization of Rabaptin-5, an effector molecule of the small GTPase
Therapeutic vaccination for chronic hepatitis B in the Trimera mouse model
From small molecule to cellular immunotherapy: therapeutic approaches for leukemia
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Current status of dendritic cell-based tumor vaccination
Advances in Cell-based Therapeutic Process Development
Editorial: Effector functions of therapeutic antibodies
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic vaccination strategies : with 9 tables
The Use of Cell-based Approaches for Inducing Therapeutic Vascularization
Novel cell-penetrating effector proteins for therapeutic applications derived from Yersinia enterocolitica
B cell immunity in lung transplant rejection - effector mechanisms and therapeutic implications
Isolation and characterization of Rabaptin-5, an effector molecule of the small GTPase
Therapeutic vaccination for chronic hepatitis B in the Trimera mouse model
From small molecule to cellular immunotherapy: therapeutic approaches for leukemia
Funtional evaluation of HMGB1 as immune therapeutic effector molecule for cell-based vaccination strategies
Current status of dendritic cell-based tumor vaccination
Advances in Cell-based Therapeutic Process Development
Editorial: Effector functions of therapeutic antibodies
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic vaccination strategies : with 9 tables
The Use of Cell-based Approaches for Inducing Therapeutic Vascularization
Novel cell-penetrating effector proteins for therapeutic applications derived from Yersinia enterocolitica
B cell immunity in lung transplant rejection - effector mechanisms and therapeutic implications
Isolation and characterization of Rabaptin-5, an effector molecule of the small GTPase
Therapeutic vaccination for chronic hepatitis B in the Trimera mouse model